Share class: HBM Healthcare Investments AG

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A16,960,0005,631,462 ( 80.91 %) 127,070 ( 1.826 %) 80.91 %

Major shareholders: HBM Healthcare Investments AG

NameEquities%Valuation
Nogra Group SICAF-SIF SA
15.81 %
1,100,612 15.81 % 235 M CHF
HBM Healthcare Investments AG
3.002 %
208,941 3.002 % 45 M CHF
Carnegie Fonder AB
1.043 %
72,617 1.043 % 15 M CHF
54,182 0.7785 % 12 M CHF
LUKB Expert Fondsleitung AG
0.5532 %
38,500 0.5532 % 8 M CHF
Union Bancaire Privée, UBP SA
0.5261 %
36,618 0.5261 % 8 M CHF
Entrepreneur Partners AG
0.4292 %
29,875 0.4292 % 6 M CHF
Delen Private Bank NV
0.2514 %
17,500 0.2514 % 4 M CHF
LPX AG
0.2443 %
17,000 0.2443 % 4 M CHF
FPS Vermögensverwaltung GmbH
0.2338 %
16,271 0.2338 % 3 M CHF
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Other18.82%
Institutional5.49%
Individuals1.02%
Unknown74.67%

Based on 1000 largest holdings

Geographical origin of shareholders

Luxembourg 16.05%
Switzerland 5.58%
Sweden 1.04%
Individuals 1.02%
Belgium 0.40%
Germany 0.35%
Finland 0.22%
Liechtenstein 0.20%
Australia 0.13%
United States 0.12%
Spain 0.11%
United Kingdom 0.10%
South Africa 0.01%

Based on 1000 largest holdings

Logo HBM Healthcare Investments AG
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Employees
700
Calendar
More about the company